Your search returned 2 results.

Results
	1.	Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial. [electronic resource] by Dieci, M V Prat, A Tagliafico, E Paré, L Ficarra, G Bisagni, G Piacentini, F Generali, D G Conte, P Guarneri, V Producer: 20171222 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer. [electronic resource] by Musolino, A Naldi, N Dieci, M V Zanoni, D Rimanti, A Boggiani, D Sgargi, P Generali, D G Piacentini, F Ambroggi, M Cagossi, K Gianni, L Sarti, S Bisagni, G Ardizzoni, A Conte, P F Guarneri, V Producer: 20170605 In: The pharmacogenomics journal vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search